Related Experiment Video
Updated: Jul 28, 2025
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
A new perspective on Alzheimer's disease: m6A modification
Lei Xia1,2,3, Fan Zhang1,2,3,4,5, Yulu Li1,2,3
1Guangxi Scientific Experimental Center of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, China.
Abstract:
As a neurodegenerative disease, Alzheimer's disease (AD) is characterized by synaptic loss, extracellular plaques of amyloid accumulation, hyperphosphorylation of tau, and neuroinflammation. Various biological processes are affected by epitranscriptomic modifications, which regulate the metabolism of mRNA in cells and regulate the expression of genes. In response to changes in m6A modification levels, the nervous system becomes dysfunctional and plays a significant role in the development of Alzheimer's disease. As a result of recent research, this paper reviews advances in the understanding of the regulatory mechanisms of m6A modification in the occurrence and development of AD. In addition, the article discusses recent research techniques related to animal models of m6A and AD. Furthermore, it discusses the possibility of studying the pathogenesis of AD at the level of the epitranscriptome, identifying early diagnostic markers, and screening for effective treatment options.
Insights
This review explores how RNA modifications, specifically N6-methyladenosine (m6A), impact Alzheimer's disease (AD) development. Understanding m6A regulation offers new avenues for early AD diagnosis and treatment.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alzheimer's disease (AD) involves synaptic loss, amyloid plaques, tau pathology, and neuroinflammation.
- Epitranscriptomic modifications, particularly N6-methyladenosine (m6A), regulate mRNA metabolism and gene expression.
- Dysregulation of m6A modification in the nervous system is implicated in AD pathogenesis.
Purpose of the Study:
- To review recent advances in understanding m6A modification regulatory mechanisms in AD.
- To discuss current research techniques for m6A and AD animal models.
- To explore the potential of epitranscriptomic studies for AD pathogenesis, early diagnosis, and treatment.
Main Methods:
- Literature review of recent research on m6A modification and Alzheimer's disease.
- Analysis of studies utilizing animal models for m6A and AD research.
- Exploration of emerging research techniques in epitranscriptomics.
Main Results:
- The review synthesizes current knowledge on the role of m6A in AD development.
- It highlights the utility of m6A-focused animal models in studying AD.
- The potential for epitranscriptomic approaches in AD research is discussed.
Conclusions:
- m6A modification plays a significant role in the nervous system's response to AD.
- Epitranscriptomic analysis offers promising strategies for early AD detection.
- Targeting m6A pathways presents potential therapeutic avenues for Alzheimer's disease.
More Related Videos
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
08:56A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Related Concept Videos
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:22Alzheimer's Disease: Treatment